Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial-Reference-Cited by-同舟云学术

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial

Published:2013-11 Issue:9903 Volume:382 Page:1485-1495
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Caroli Anna,Perico Norberto,Perna Annalisa,Antiga Luca,Brambilla Paolo,Pisani Antonio,Visciano Bianca,Imbriaco Massimo,Messa Piergiorgio,Cerutti Roberta,Dugo Mauro,Cancian Luca,Buongiorno Erasmo,De Pascalis Antonio,Gaspari Flavio,Carrara Fabiola,Rubis Nadia,Prandini Silvia,Remuzzi Andrea,Remuzzi Giuseppe,Ruggenenti Piero

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. Clinical practice. Autosomal dominant polycystic kidney disease;Grantham;N Engl J Med,2008

2. Mechanisms of progression in autosomal dominant polycystic kidney disease;Grantham;Kidney Int Suppl,1997

3. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes;Grantham;Clin J Am Soc Nephrol,2006

4. Chloride and fluid secretion in polycystic kidney disease;Sullivan;J Am Soc Nephrol,1998

5. Somatostatin inhibits CNP-induced stimulation of shark rectal gland;Silva;Bull Mt Desert Island Biol Lab,1991

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GFR measurement in patients with CKD: Performance and feasibility of simplified iohexol plasma clearance techniques;PLOS ONE;2024-07-17

2. Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights;Expert Opinion on Investigational Drugs;2024-04-21

3. The screening, diagnosis, and management of patients with autosomal dominant polycystic kidney disease: A national consensus statement from Taiwan;Nephrology;2024-03-10

4. A unique subset of pericystic endothelium associates with aberrant microvascular remodelling and impaired blood perfusion early in polycystic kidney disease;2024-03-06

5. Validation of the Mayo Imaging Classification System for Predicting Kidney Outcomes in ADPKD;Clinical Journal of the American Society of Nephrology;2024-02-26